These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 22261689

  • 1. Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing mendelian randomization approach.
    Niu W, Liu Y, Qi Y, Wu Z, Zhu D, Jin W.
    Int J Cardiol; 2012 May 31; 157(2):243-52. PubMed ID: 22261689
    [Abstract] [Full Text] [Related]

  • 2. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW, Li JC, Zhang M, Wang JZ, Li BH, Liu Y, Liao SQ, Zhang MJ, Gao CY, Zhang LL.
    Gene; 2013 Oct 15; 529(1):94-103. PubMed ID: 23954871
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN, Carey JA, Barnard J, Fildes JE, Pravica V, Yonan N, Hutchinson IV.
    Heart Surg Forum; 2005 Oct 15; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Is interleukin-6 circulating levels associated with coronary artery disease?
    Liu C.
    Int J Cardiol; 2012 May 31; 157(2):270; author reply 253-4. PubMed ID: 22456261
    [No Abstract] [Full Text] [Related]

  • 7. Association of interleukin 6 -174 G/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysis.
    Rai H, Colleran R, Cassese S, Joner M, Kastrati A, Byrne RA.
    Inflamm Res; 2021 Dec 31; 70(10-12):1075-1087. PubMed ID: 34595552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circulating cholesteryl ester transfer protein and coronary heart disease: mendelian randomization meta-analysis.
    Niu W, Qi Y.
    Circ Cardiovasc Genet; 2015 Feb 31; 8(1):114-21. PubMed ID: 25561046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.
    Marso SP, House JA, Hopkins PJ.
    Int J Immunogenet; 2006 Oct 31; 33(5):347-54. PubMed ID: 16984279
    [Abstract] [Full Text] [Related]

  • 13. Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis.
    Fang S, Wang L, Jia C.
    Thromb Res; 2010 May 31; 125(5):e197-201. PubMed ID: 20100625
    [Abstract] [Full Text] [Related]

  • 14. Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization.
    Tian G, Mi J, Wei X, Zhao D, Qiao L, Yang C, Li X, Zhang S, Li X, Wang B.
    Sci Rep; 2015 Jun 22; 5():11394. PubMed ID: 26096712
    [Abstract] [Full Text] [Related]

  • 15. Serum total bilirubin levels and coronary heart disease--Causal association or epiphenomenon?
    Kunutsor SK.
    Exp Gerontol; 2015 Dec 22; 72():63-6. PubMed ID: 26408227
    [Abstract] [Full Text] [Related]

  • 16. Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease.
    Manousaki D, Mokry LE, Ross S, Goltzman D, Richards JB.
    Circ Cardiovasc Genet; 2016 Aug 22; 9(4):349-56. PubMed ID: 27418593
    [Abstract] [Full Text] [Related]

  • 17. The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis.
    Lee YH, Lee HS, Choi SJ, Ji JD, Song GG.
    Lupus; 2012 Jan 22; 21(1):60-7. PubMed ID: 22004976
    [Abstract] [Full Text] [Related]

  • 18. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients.
    Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, Lio D, Mocchegiani E.
    Biogerontology; 2006 Jan 22; 7(5-6):347-56. PubMed ID: 16953332
    [Abstract] [Full Text] [Related]

  • 19. Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease.
    van Durme YM, Lahousse L, Verhamme KM, Stolk L, Eijgelsheim M, Loth DW, Uitterlinden AG, Breteler MM, Joos GF, Hofman A, Stricker BH, Brusselle GG.
    Respiration; 2011 Jan 22; 82(6):530-8. PubMed ID: 21997388
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
    Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W.
    BMC Cardiovasc Disord; 2005 May 20; 5(1):10. PubMed ID: 15943888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.